252 related articles for article (PubMed ID: 28532503)
21. PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2.
Wishart GC; Bajdik CD; Dicks E; Provenzano E; Schmidt MK; Sherman M; Greenberg DC; Green AR; Gelmon KA; Kosma VM; Olson JE; Beckmann MW; Winqvist R; Cross SS; Severi G; Huntsman D; Pylkäs K; Ellis I; Nielsen TO; Giles G; Blomqvist C; Fasching PA; Couch FJ; Rakha E; Foulkes WD; Blows FM; Bégin LR; van't Veer LJ; Southey M; Nevanlinna H; Mannermaa A; Cox A; Cheang M; Baglietto L; Caldas C; Garcia-Closas M; Pharoah PD
Br J Cancer; 2012 Aug; 107(5):800-7. PubMed ID: 22850554
[TBL] [Abstract][Full Text] [Related]
22. Androgen Receptor Expression and Breast Cancer Survival: Results From the Nurses' Health Studies.
Kensler KH; Poole EM; Heng YJ; Collins LC; Glass B; Beck AH; Hazra A; Rosner BA; Eliassen AH; Hankinson SE; Winer EP; Brown M; Tamimi RM
J Natl Cancer Inst; 2019 Jul; 111(7):700-708. PubMed ID: 30445651
[TBL] [Abstract][Full Text] [Related]
23. An estrogen receptor (ER)-related signature in predicting prognosis of ER-positive breast cancer following endocrine treatment.
Tang J; Cui Q; Zhang D; Liao X; Zhu J; Wu G
J Cell Mol Med; 2019 Aug; 23(8):4980-4990. PubMed ID: 31124293
[TBL] [Abstract][Full Text] [Related]
24. Development and External Validation of Prediction Models for 10-Year Survival of Invasive Breast Cancer. Comparison with PREDICT and CancerMath.
Karapanagiotis S; Pharoah PDP; Jackson CH; Newcombe PJ
Clin Cancer Res; 2018 May; 24(9):2110-2115. PubMed ID: 29444929
[No Abstract] [Full Text] [Related]
25. Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model.
Thurtle DR; Greenberg DC; Lee LS; Huang HH; Pharoah PD; Gnanapragasam VJ
PLoS Med; 2019 Mar; 16(3):e1002758. PubMed ID: 30860997
[TBL] [Abstract][Full Text] [Related]
26. Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature.
Tutt A; Wang A; Rowland C; Gillett C; Lau K; Chew K; Dai H; Kwok S; Ryder K; Shu H; Springall R; Cane P; McCallie B; Kam-Morgan L; Anderson S; Buerger H; Gray J; Bennington J; Esserman L; Hastie T; Broder S; Sninsky J; Brandt B; Waldman F
BMC Cancer; 2008 Nov; 8():339. PubMed ID: 19025599
[TBL] [Abstract][Full Text] [Related]
27. Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis.
Harnan S; Tappenden P; Cooper K; Stevens J; Bessey A; Rafia R; Ward S; Wong R; Stein RC; Brown J
Health Technol Assess; 2019 Jun; 23(30):1-328. PubMed ID: 31264581
[TBL] [Abstract][Full Text] [Related]
28. GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value.
Voduc D; Cheang M; Nielsen T
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):365-73. PubMed ID: 18268121
[TBL] [Abstract][Full Text] [Related]
29. Prognostic models for breast cancer: a systematic review.
Phung MT; Tin Tin S; Elwood JM
BMC Cancer; 2019 Mar; 19(1):230. PubMed ID: 30871490
[TBL] [Abstract][Full Text] [Related]
30. Determinants of lymph node status in women with breast cancer: A hospital based study from eastern India.
Chakraborty A; Bose CK; Basak J; Sen AN; Mishra R; Mukhopadhyay A
Indian J Med Res; 2016 May; 143(Supplement):S45-S51. PubMed ID: 27748277
[TBL] [Abstract][Full Text] [Related]
31. A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer.
Vollan HK; Rueda OM; Chin SF; Curtis C; Turashvili G; Shah S; Lingjærde OC; Yuan Y; Ng CK; Dunning MJ; Dicks E; Provenzano E; Sammut S; McKinney S; Ellis IO; Pinder S; Purushotham A; Murphy LC; Kristensen VN; ; Brenton JD; Pharoah PD; Børresen-Dale AL; Aparicio S; Caldas C
Mol Oncol; 2015 Jan; 9(1):115-27. PubMed ID: 25169931
[TBL] [Abstract][Full Text] [Related]
32. Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years.
Engelhardt EG; van den Broek AJ; Linn SC; Wishart GC; Rutgers EJT; van de Velde AO; Smit VTHBM; Voogd AC; Siesling S; Brinkhuis M; Seynaeve C; Westenend PJ; Stiggelbout AM; Tollenaar RAEM; van Leeuwen FE; van 't Veer LJ; Ravdin PM; Pharaoh PDP; Schmidt MK
Eur J Cancer; 2017 Jun; 78():37-44. PubMed ID: 28412587
[TBL] [Abstract][Full Text] [Related]
33. Prognostic information of a previously diagnosed sister is an independent prognosticator for a newly diagnosed sister with breast cancer.
Lindström LS; Li J; Lee M; Einbeigi Z; Hartman M; Hall P; Czene K
Ann Oncol; 2014 Oct; 25(10):1966-1972. PubMed ID: 25057175
[TBL] [Abstract][Full Text] [Related]
34. Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer.
Jankowitz RC; Cooper K; Erlander MG; Ma XJ; Kesty NC; Li H; Chivukula M; Brufsky A
Breast Cancer Res; 2011 Oct; 13(5):R98. PubMed ID: 21999244
[TBL] [Abstract][Full Text] [Related]
35. External validation of the PREDICT tool in Spanish women with breast cancer participating in population-based screening programmes.
Aguirre U; García-Gutiérrez S; Romero A; Domingo L; Castells X; Sala M;
J Eval Clin Pract; 2019 Oct; 25(5):873-880. PubMed ID: 30548721
[TBL] [Abstract][Full Text] [Related]
36. Development of a prediction model for breast cancer based on the national cancer registry in Taiwan.
Huang CC; Chan SY; Lee WC; Chiang CJ; Lu TP; Cheng SH
Breast Cancer Res; 2019 Aug; 21(1):92. PubMed ID: 31409418
[TBL] [Abstract][Full Text] [Related]
37. Worse characteristics can predict survival effectively in bilateral primary breast cancer: A competing risk nomogram using the SEER database.
Shen K; Yao L; Wei J; Luo Z; Yu W; Zhai H; Wang J; Chen L; Fu D
Cancer Med; 2019 Dec; 8(18):7890-7902. PubMed ID: 31663683
[TBL] [Abstract][Full Text] [Related]
38. A multiple breast cancer stem cell model to predict recurrence of T
Qiu Y; Wang L; Zhong X; Li L; Chen F; Xiao L; Liu F; Fu B; Zheng H; Ye F; Bu H
BMC Cancer; 2019 Jul; 19(1):729. PubMed ID: 31340763
[TBL] [Abstract][Full Text] [Related]
39. Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers.
Liu D
Breast Cancer Res Treat; 2020 Aug; 183(1):95-105. PubMed ID: 32601968
[TBL] [Abstract][Full Text] [Related]
40. An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis.
Maishman T; Copson E; Stanton L; Gerty S; Dicks E; Durcan L; Wishart GC; Pharoah P; ; Eccles D
Br J Cancer; 2015 Mar; 112(6):983-91. PubMed ID: 25675148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]